210 related articles for article (PubMed ID: 24551087)
21. Perinatal sources of mesenchymal stem cells: Wharton's jelly, amnion and chorion.
Witkowska-Zimny M; Wrobel E
Cell Mol Biol Lett; 2011 Sep; 16(3):493-514. PubMed ID: 21786036
[TBL] [Abstract][Full Text] [Related]
22. Bone marrow mesenchymal stem cell-derived endothelial cells increase capillary density and accelerate angiogenesis in mouse hindlimb ischemia model.
Yao Z; Liu H; Yang M; Bai Y; Zhang B; Wang C; Yan Z; Niu G; Zou Y; Li Y
Stem Cell Res Ther; 2020 Jun; 11(1):221. PubMed ID: 32513272
[TBL] [Abstract][Full Text] [Related]
23. Platelet-rich plasma improves the therapeutic efficacy of mesenchymal stem cells by enhancing their secretion of angiogenic factors in a combined radiation and wound injury model.
Myung H; Jang H; Myung JK; Lee C; Lee J; Kang J; Jang WS; Lee SJ; Kim H; Kim HY; Park S; Shim S
Exp Dermatol; 2020 Feb; 29(2):158-167. PubMed ID: 31560791
[TBL] [Abstract][Full Text] [Related]
24. A mechanistic evaluation of the angiogenic properties of a dehydrated amnion chorion membrane in vitro and in vivo.
McQuilling JP; Burnette M; Kimmerling KA; Kammer M; Mowry KC
Wound Repair Regen; 2019 Nov; 27(6):609-621. PubMed ID: 31425636
[TBL] [Abstract][Full Text] [Related]
25. Human umbilical cord tissue-derived mesenchymal stromal cells attenuate remodeling after myocardial infarction by proangiogenic, antiapoptotic, and endogenous cell-activation mechanisms.
Santos Nascimento D; Mosqueira D; Sousa LM; Teixeira M; Filipe M; Resende TP; Araújo AF; Valente M; Almeida J; Martins JP; Santos JM; Bárcia RN; Cruz P; Cruz H; Pinto-do-Ó P
Stem Cell Res Ther; 2014 Jan; 5(1):5. PubMed ID: 24411922
[TBL] [Abstract][Full Text] [Related]
26. C-Met-Activated Mesenchymal Stem Cells Rescue Ischemic Damage via Interaction with Cellular Prion Protein.
Han YS; Yun SP; Lee JH; Kwon SH; Kim S; Hur J; Lee SH
Cell Physiol Biochem; 2018; 46(5):1835-1848. PubMed ID: 29705776
[TBL] [Abstract][Full Text] [Related]
27. In vivo efficacy of endothelial growth medium stimulated mesenchymal stem cells derived from patients with critical limb ischemia.
Al-Rifai R; Nguyen P; Bouland N; Terryn C; Kanagaratnam L; Poitevin G; François C; Boisson-Vidal C; Sevestre MA; Tournois C
J Transl Med; 2019 Aug; 17(1):261. PubMed ID: 31399109
[TBL] [Abstract][Full Text] [Related]
28. Regenerative Potential of the Product "CardioCell" Derived from the Wharton's Jelly Mesenchymal Stem Cells for Treating Hindlimb Ischemia.
Musiał-Wysocka A; Kot M; Sułkowski M; Majka M
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31540534
[TBL] [Abstract][Full Text] [Related]
29. Tumor necrosis factor-α-activated mesenchymal stem cells promote endothelial progenitor cell homing and angiogenesis.
Kwon YW; Heo SC; Jeong GO; Yoon JW; Mo WM; Lee MJ; Jang IH; Kwon SM; Lee JS; Kim JH
Biochim Biophys Acta; 2013 Dec; 1832(12):2136-44. PubMed ID: 23959047
[TBL] [Abstract][Full Text] [Related]
30. Allogeneic injection of fetal membrane-derived mesenchymal stem cells induces therapeutic angiogenesis in a rat model of hind limb ischemia.
Ishikane S; Ohnishi S; Yamahara K; Sada M; Harada K; Mishima K; Iwasaki K; Fujiwara M; Kitamura S; Nagaya N; Ikeda T
Stem Cells; 2008 Oct; 26(10):2625-33. PubMed ID: 18669910
[TBL] [Abstract][Full Text] [Related]
31. Neovascularization in a mouse model via stem cells derived from human fetal amniotic membranes.
Kim HG; Choi OH
Heart Vessels; 2011 Mar; 26(2):196-205. PubMed ID: 21188388
[TBL] [Abstract][Full Text] [Related]
32. Comparison of the proliferation, migration and angiogenic properties of human amniotic epithelial and mesenchymal stem cells and their effects on endothelial cells.
Wu Q; Fang T; Lang H; Chen M; Shi P; Pang X; Qi G
Int J Mol Med; 2017 Apr; 39(4):918-926. PubMed ID: 28259958
[TBL] [Abstract][Full Text] [Related]
33. Dehydrated human amnion/chorion membrane regulates stem cell activity in vitro.
Massee M; Chinn K; Lei J; Lim JJ; Young CS; Koob TJ
J Biomed Mater Res B Appl Biomater; 2016 Oct; 104(7):1495-503. PubMed ID: 26175122
[TBL] [Abstract][Full Text] [Related]
34. Protein profiling and angiogenic effect of hypoxia-cultured human umbilical cord blood-derived mesenchymal stem cells in hindlimb ischemia.
Han KH; Kim AK; Kim MH; Kim DH; Go HN; Kang D; Chang JW; Choi SW; Kang KS; Kim DI
Tissue Cell; 2017 Dec; 49(6):680-690. PubMed ID: 28958480
[TBL] [Abstract][Full Text] [Related]
35. Comparison of Human Amniotic, Chorionic, and Umbilical Cord Multipotent Mesenchymal Stem Cells Regarding Their Capacity for Differentiation Toward Female Germ Cells.
Asgari HR; Akbari M; Yazdekhasti H; Rajabi Z; Navid S; Aliakbari F; Abbasi N; Aval FS; Shams A; Abbasi M
Cell Reprogram; 2017 Feb; 19(1):44-53. PubMed ID: 28112985
[TBL] [Abstract][Full Text] [Related]
36. The Immunomodulatory Properties of the Human Amnion-Derived Mesenchymal Stromal/Stem Cells Are Induced by INF-γ Produced by Activated Lymphomonocytes and Are Mediated by Cell-To-Cell Contact and Soluble Factors.
Bulati M; Miceli V; Gallo A; Amico G; Carcione C; Pampalone M; Conaldi PG
Front Immunol; 2020; 11():54. PubMed ID: 32117234
[TBL] [Abstract][Full Text] [Related]
37. The potential of mesenchymal stem cells derived from amniotic membrane and amniotic fluid for neuronal regenerative therapy.
Kim EY; Lee KB; Kim MK
BMB Rep; 2014 Mar; 47(3):135-40. PubMed ID: 24499672
[TBL] [Abstract][Full Text] [Related]
38. IGF-1C domain-modified hydrogel enhances therapeutic potential of mesenchymal stem cells for hindlimb ischemia.
Zhao N; Yue Z; Cui J; Yao Y; Song X; Cui B; Qi X; Han Z; Han ZC; Guo Z; He ZX; Li Z
Stem Cell Res Ther; 2019 Apr; 10(1):129. PubMed ID: 31036073
[TBL] [Abstract][Full Text] [Related]
39. Engraftment potential of human amnion and chorion cells derived from term placenta.
Bailo M; Soncini M; Vertua E; Signoroni PB; Sanzone S; Lombardi G; Arienti D; Calamani F; Zatti D; Paul P; Albertini A; Zorzi F; Cavagnini A; Candotti F; Wengler GS; Parolini O
Transplantation; 2004 Nov; 78(10):1439-48. PubMed ID: 15599307
[TBL] [Abstract][Full Text] [Related]
40. Human amnion-derived mesenchymal stem cells attenuate xenogeneic graft-versus-host disease by preventing T cell activation and proliferation.
Tago Y; Kobayashi C; Ogura M; Wada J; Yamaguchi S; Yamaguchi T; Hayashi M; Nakaishi T; Kubo H; Ueda Y
Sci Rep; 2021 Jan; 11(1):2406. PubMed ID: 33510297
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
